Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-104443
Filing Date
2024-09-30
Accepted
2024-09-30 18:36:00
Documents
2
Period of Report
2024-09-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425266-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425266-7_4seq1.xml 4 4136
2 EXHIBIT 24 tm2425266d7_ex24.htm EX-24 8142
  Complete submission text file 0001104659-24-104443.txt   13939
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROVENTION BIO, INC. P.O. BOX 666 OLDWICK NJ 08858
Business Address
Pisano Wayne (Reporting) CIK: 0001743611 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 241340829